Next 10 |
2024-04-02 09:53:03 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cardiol Therapeutics (NASDAQ: CRDL ) just reported results for the fourth quarter of 2023. Cardiol Therapeutics reported earnings per share of -9 cents. This was above the...
Completed patient enrollment in the Phase II MAvERIC-Pilot study evaluating CardiolRx™ in patients with recurrent pericarditis, with topline results expected in Q2 2024 CardiolRx™ granted U.S. FDA Orphan Drug Designation for the treatment of pericarditis, which includes recurrent p...
2024-03-27 08:24:20 ET More on premarket gainers & stock Veritone: Not An AI Stock To Bank On Veritone, Inc. (VERI) Q4 2023 Earnings Call Transcript Mesoblast Limited (MESO) Q2 2024 Earnings Call Transcript Mesoblast gains as FDA backs regulatory plans fo...
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...
Topline Results Expected in Q2 2024 This is a Designated News Release. Toronto, Ontario--(Newsfile Corp. - February 21, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (" Cardiol " or the " Company "), a clinical-stage life sciences company focused on the research and clinical ...
2024-02-16 09:10:00 ET February 16, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Biotech sector. The newest biotech companies are involved in treatment of heart disease, ...
2024-02-16 08:27:44 ET Losers: Trupanion TRUP -24% after Q4 earnings release . Bloom Energy Corp BE -19% after Q4 earnings release . Infobird Co Ltd ( IFBD ) -20% . Greenpro Capital Corp ( GRNQ ) -16% . Roku ROKU -17% after Q4 earn...
2024-02-15 14:25:53 ET %OrphanDrug designation, or ODD, is valuable on both a humanitarian and a profitability basis. And this company is seeing shares rally following news that it was granted the designation for the treatment of %Pericarditis , the swelling, and irritation of the t...
2024-02-15 12:04:40 ET More on Cardiol Therapeutics Seeking Alpha’s Quant Rating on Cardiol Therapeutics Historical earnings data for Cardiol Therapeutics Financial information for Cardiol Therapeutics Read the full article on Seeking Alpha For...
2024-02-15 10:00:00 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Communication Services, Info ...
News, Short Squeeze, Breakout and More Instantly...
Cardiol Therapeutics Inc. Company Name:
CRDL Stock Symbol:
NASDAQ Market:
Completed patient enrollment in the Phase II MAvERIC-Pilot study evaluating CardiolRx™ in patients with recurrent pericarditis, with topline results expected in Q2 2024 CardiolRx™ granted U.S. FDA Orphan Drug Designation for the treatment of pericarditis, which includes recurrent p...
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...